Brenda Shanahan joined the Board on 15 September 2017.
Brenda is a graduate of Melbourne University in Economics and Commerce and a Fellow of the Institute of Directors. With a finance research background in Australian and overseas economies and share markets, she has held a number of executive positions including as Managing Director and a member of the international board of WM Mercer Investment Consulting for Australia and Asia.
Brenda is a former director of Equitilink Limited and of ASX-listed Challenger Financial Services as an independent non-executive director of Challenger Limited, where she was a member of the group Risk Committee, Group Audit Committee, Remuneration Committee and Nomination Committee.
Her other directorships include Bell Financial Group Limited, Clinuvel Pharmaceuticals Limited, DMP Asset Management Limited, St Vincent's Medical Research Institute in Melbourne Foundation, and as Chair of the Aitkenhead Centre for Medical Discovery. Brenda was recently bestowed with an honorary Doctorate from Swinburne University of Technology.